Safety, Tolerability and Efficacy of a Vaccine Against Essential Hypertension

Clinical trial NCT00710372 · COMPLETED

Trial details

NCT number: NCT00710372
Sponsor: Cytos Biotechnology AG
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Mild Essential Hypertension Moderate Essential Hypertension

Start date: 2008-06-01
Primary completion: 2009-07-01
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.